These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29120577)

  • 21. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
    PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus and multiple sclerosis.
    Pohl D
    J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus candidate genes and multiple sclerosis.
    Claire Simon K; Schmidt H; Loud S; Ascherio A
    Mult Scler Relat Disord; 2015 Jan; 4(1):60-4. PubMed ID: 25787055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strains of Epstein-Barr virus infecting multiple sclerosis patients.
    Brennan RM; Burrows JM; Bell MJ; Bromham L; Csurhes PA; Lenarczyk A; Sverndal J; Klintenstedt J; Pender MP; Burrows SR
    Mult Scler; 2010 Jun; 16(6):643-51. PubMed ID: 20350958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis.
    Wang YF; He DD; Liang HW; Yang D; Yue H; Zhang XM; Wang R; Li B; Yang HX; Liu Y; Chen Y; Duan YX; Zhang CY; Chen X; Fu J
    Clin Exp Immunol; 2017 Jul; 189(1):120-126. PubMed ID: 28253538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
    Castellazzi M; Delbue S; Elia F; Gastaldi M; Franciotta D; Rizzo R; Bellini T; Bergamaschi R; Granieri E; Fainardi E
    Dis Markers; 2015; 2015():901312. PubMed ID: 26101453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis.
    Santón A; Cristóbal E; Aparicio M; Royuela A; Villar LM; Alvarez-Cermeño JC
    Mult Scler; 2011 Nov; 17(11):1295-300. PubMed ID: 21757537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
    Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
    J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
    J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
    Levin LI; Munger KL; O'Reilly EJ; Falk KI; Ascherio A
    Ann Neurol; 2010 Jun; 67(6):824-30. PubMed ID: 20517945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EBNA1 and LMP1 variants in multiple sclerosis cases and controls.
    Simon KC; Yang X; Munger KL; Ascherio A
    Acta Neurol Scand; 2011 Jul; 124(1):53-8. PubMed ID: 20636447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.
    Hassani A; Corboy JR; Al-Salam S; Khan G
    PLoS One; 2018; 13(2):e0192109. PubMed ID: 29394264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serostatus of Epstein-Barr virus in Iranian MS patients.
    Karampoor S; Zahednasab H; Pirkouh AA; Monavari SH; Ramagopalan S; Keyvani H
    Acta Neurol Belg; 2016 Mar; 116(1):43-6. PubMed ID: 26071762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Epstein-Barr virus infection with multiple sclerosis in India.
    Pandit L; Malli C; D'Cunha A; Shetty R; Singhal B
    J Neurol Sci; 2013 Feb; 325(1-2):86-9. PubMed ID: 23312038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus cause of multiple sclerosis.
    Tselis A
    Curr Opin Rheumatol; 2012 Jul; 24(4):424-8. PubMed ID: 22617821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus genotypes in multiple sclerosis.
    Lindsey JW; Patel S; Zou J
    Acta Neurol Scand; 2008 Feb; 117(2):141-4. PubMed ID: 18184350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis.
    Pohl D; Krone B; Rostasy K; Kahler E; Brunner E; Lehnert M; Wagner HJ; Gärtner J; Hanefeld F
    Neurology; 2006 Dec; 67(11):2063-5. PubMed ID: 17159123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.